Discover your next big idea at PACK EXPO Las Vegas
Experience a breakthrough in packaging & processing and transform your business with solutions from 2,300 suppliers spanning all industries. Click to learn more.

Intelligrated: High density sliding shoe sorter

The IntelliSort HDS sliding shoe sorter is an ideal solution for high-throughput e-commerce operations, offering fast, precise diverts of a variety of product and packaging types – even polybags.

High density sliding shoe sorter
High density sliding shoe sorter

Its innovative dual-sided design accommodates a high density of chutes in minimal floor space, making the sorter an excellent fit for zone-skipping applications that pre-sort orders according to destination region before releasing them to last-mile parcel carriers. The patented soft touch divert technology provides gentle product control and reduced item impact speed without compromising throughput or divert accuracy.

As companies face dimensional weight pricing, reduced secondary packaging and other e-commerce pressures, the IntelliSort HDS enables a competitive advantage by keeping shipping costs low while increasing speed of delivery.

Fill out the form below to request more information about Intelligrated: High density sliding shoe sorter
Annual Outlook Report: Workforce
Hiring remains a major challenge in packaging, with 78% struggling to fill unskilled roles and 84% lacking experienced workers. As automation grows, companies must rethink hiring and training. Download the full report for key insights.
Download Now
Annual Outlook Report: Workforce
Pharmaceutical Innovations Report
Discover the latest breakthrough packaging technologies shaping the pharmaceutical sector. This report dives into cutting-edge innovations, from smart containers that enhance patient safety to eco-friendly materials poised to transform the industry’s sustainability practices. All from PACK EXPO. Learn how forward-thinking strategies are driving efficiency and redefining what’s possible in pharma packaging.
Learn More
Pharmaceutical Innovations Report